Insider · CIK 0002082926
Scott Michael Galovan
Files at AVNS (AVANOS MEDICAL, INC.). First filing -, latest -.
In brief
Scott Michael Galovan files SEC Form 4 as CFO at AVNS (AVANOS MEDICAL, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Scott Michael Galovan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | AVNS AVANOS MEDICAL, INC. | DDisposition to issuer Common Stock | -135,596 | $25.00 | $3.4M | 0 | Jul 28, 2026 |
| Jul 27, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +96,121 | $0.00 | $0 | 96,121 | Jul 28, 2026 |
| Jul 27, 2026 | AVNS AVANOS MEDICAL, INC. | DDisposition to issuer Common Stock | -96,121 | $25.00 | $2.4M | 0 | Jul 28, 2026 |
| Jul 27, 2026 | AVNS AVANOS MEDICAL, INC. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -69,630 | - | - | 0 | Jul 28, 2026 |
| Jul 27, 2026 | AVNS AVANOS MEDICAL, INC. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -21,038 | - | - | 0 | Jul 28, 2026 |
| Apr 22, 2026 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -4,228 | $24.64 | $104k | 135,596 | Apr 24, 2026 |
| Mar 13, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +29,481 | $0.00 | $0 | 139,824 | Apr 1, 2026 |
| Mar 13, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +29,481 | $0.00 | $0 | 139,824 | Apr 1, 2026 |
| Mar 13, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +70,115 | $0.00 | $0 | 96,697 | Apr 1, 2026 |
| Mar 13, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +69,630 | $0.00 | $0 | 96,212 | Apr 1, 2026 |
| Mar 13, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +29,481 | $0.00 | $0 | 139,824 | Mar 17, 2026 |
| Mar 13, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +69,630 | $0.00 | $0 | 96,212 | Mar 17, 2026 |
| Mar 9, 2026 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -1,119 | $13.29 | $15k | 110,343 | Mar 11, 2026 |
| Mar 6, 2026 | AVNS AVANOS MEDICAL, INC. | MOption exercise Common Stock | +5,907 | $13.79 | $81k | 116,916 | Mar 10, 2026 |
| Mar 6, 2026 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -2,356 | $13.79 | $32k | 114,560 | Mar 10, 2026 |
| Mar 6, 2026 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -1,057 | $13.79 | $15k | 113,503 | Mar 10, 2026 |
| Mar 6, 2026 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -2,041 | $13.79 | $28k | 111,462 | Mar 10, 2026 |
Questions about Scott Michael Galovan
Answered from the filings on this page, as of the latest one.
Is Scott Michael Galovan buying or selling?
Scott Michael Galovan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Scott Michael Galovan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Scott Michael Galovan has 0.
Where does Scott Michael Galovan file Form 4?
Scott Michael Galovan has filed Form 4 at AVNS (AVANOS MEDICAL, INC.) as SVP, Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.